Under the new policy, all academic papers on Covid-19 will be subject to extra vetting before being submitted for publication. Studies on the origin of the virus will receive extra scrutiny and must be approved by central government officials, according to the now-deleted posts.
A medical expert in Hong Kong who collaborated with mainland researchers to publish a clinical analysis of Covid-19 cases in an international medical journal said his work did not undergo such vetting in February.
And now, Chinese authorities appear to be tightening their grip on the publication of Covid-19 research. CNN has reached out to China’s foreign ministry for comment.
According to the directive issued recently by the Ministry of Education’s science and technology department, “academic papers about tracing the origin of the virus must be strictly and tightly managed.”
The directive lays out layers of approval for these papers, starting with the academic committees at universities. They are then required to be sent to the education ministry’s science and technology department, which then forwards the papers to a task-force under the State Council for vetting. Only after the universities hear back from the task-force can the papers be submitted to journals.
Other papers on Covid-19 will be vetted by universities’ academic committees, based on conditions such as the “academic value” of the study, and whether the “timing for publishing” is right.
The directive is based on instructions issued during a March 25 meeting held by the State Council’s task-force on the prevention and control of Covid-19, it said.
When CNN called a contact number left at the end of the notice, a staff member of the education ministry’s science and technology department confirmed they had issued the directive.
“It is not supposed to be made public — it is an internal document,” said the person, who refused to reveal his name.
A few hours later, the Fudan University page was taken down.
“The process was really simple then,” he told CNN over the phone.
Hui said he was still revising the draft of the paper until 3 a.m. on the day it was due for submission, and the paper was sent to the NEJM by midday.
“There was completely no restriction at all,” he said.
“I don’t know if it is because some researchers published something that is considered sensitive domestically in China. (I’m) not sure if it is because of the controversy about the origin of the virus later, and the non-sensitive stuff becomes sensitive too.”
Origin of the virus
In late December, Wuhan reported the first cases of the coronavirus, linked by authorities to a seafood market in the city. Scientists in China and the West have said the virus is likely to have originated in bats and jumped to humans from an intermediate host — just like its cousin that caused the SARS epidemic in 2002 and 2003.
However, parts of Chinese social media and even the country’s government appear to have launched a concerted campaign to question the origin of the virus.
In China, research papers on the coronavirus are already subjected to layers of vetting after they are submitted to Chinese academic journals, according to an editor at a Chinese medical journal.
Wang Lan, the editorial director of the Chinese Journal of Epidemiology, said all Covid-19 papers have to go through an approval process for “major topics” after being submitted to her journal.
“It has always been the case,” she told CNN. “They have to be approved by three levels of organizations. It’s a long process.”
CNN’s Steven Jiang and Alexandra Lin contributed reporting.